ClotCare: Blood Clots, Stroke, Heart Attack
Monday, December 9, 2024
Home   |   DVT/PE   |   Blood Clots   |   Coumadin/Warfarin   |   New Patients   |   Self Testing   |   Email List   |   Donate

Pick a Topic:

Find info on a:

We subscribe to the HONcode principles of the HON Foundation. Click to verify.
ClotCare complies with the HONcode standard for trustworthy health
information:
verify here.

ClotCare is a member of the Coalition to Prevent Deep Vein Thrombosis (DVT Coalition)  ClotCare is a member organization of the Coalition to Prevent Deep Vein Thrombosis. Click here to learn more about the Coalition to Prevent Deep Vein Thrombosis and DVT Awareness Month, which is held each March.

FDA advisory panel recommends approval of dronedarone

Henry I. Bussey, Pharm.D., FCCP, FAHA
March, 2009

FDA advisory panel recommends approval of dronedarone (an amiodarone-like antiarrhythmic) with a split vote (10 to 3) and "cautious yes" votes. The FDA does not have to follow the panel's recommendation, but it usually does. The primary concern about this drug is based on an increased death rate in an earlier trial of patients with severe heart failure. A more recent study that excluded patients with severe heart failure did not find an increased mortality rate but did report a 24% reduction in the primary endpoint of death from any cause or cardiovascular hospitalization (the difference was due to a reduction in cardiovascular hospitalizations, not mortality). Some authorities also indicated a desire for more long-term data.

More information is available at the links below:

FDA advisory panel recommends dronedarone approval for atrial fib - article on theheart.org

Dronedarone (an investigational anti-arrhythmic) reduces hospitalizations and cardiovascular death but not total mortality in selected patients with atrial fibrillation (the ATHENA trial) - ClotCare article

Ask a question about blood clots or anticoagulant medications Have questions? Ask ClotCare. Send questions by email to webmaster@clotcare.org.

ClotCare is a 501(c)(3) non-profit organization generously supported by your tax-deductible donations and grants from our industry supporters.

Blood Clot Activities Calendar

New Postings:

Click here to view full list of new postings
ClotCare Home | New Postings | Patient Postings | Clinician Postings | Join Our Email List | Useful Web Links
CE Opportunities | Training Programs | DVT & PE Stories | Editorial Board | Financial Support
About ClotCare | DVT Coalition | Donate to ClotCare | Contact Us
Key topics discussed on ClotCare include: Blood Clots | Deep Vein Thrombosis (DVT) | Pulmonary Embolism (PE) | Atrial Fibrillation (A. Fib or AF) | Heart Attack | Stroke | Transient Ischemic Attack (TIA) | Mini Stroke | Bleeding Complications | Vascular Surgery | Surgical Blood Clot Removal | Warfarin | Coumadin | Lovenox | Low Molecular Weight Heparin (LMWH) | Heparin | Anticoagulants | Plavix | Aspirin | Antiplatelets | Blood Thinners
Copyright 2000-2018 by ClotCare. All rights reserved.
Terms, Conditions, & Privacy | Image Copyright Information
19260 Stone Oak Parkway, Suite 101 | San Antonio, TX 78258 | 210-860-0487
Send comments to webmaster@clotcare.org.
Monday, December 9, 2024